Učitavanje...

Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors.

Aminoguanidine decreases the formation of advanced glycosylation end products that occurs during chronic hyperglycemia. Presumably this occurs because early glycosylation products preferentially bind to aminoguanidine rather than to lysine groups of adjacent proteins. Because oxidative modification...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Picard, S, Parthasarathy, S, Fruebis, J, Witztum, J L
Format: Artigo
Jezik:Inglês
Izdano: 1992
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC49607/
https://ncbi.nlm.nih.gov/pubmed/1495978
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!